P01.15 Personalized combination of neoadjuvant...

Journal for ImmunoTherapy of Cancer 2020 / 10 Vol. 8; Iss. Suppl 2

P01.15 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in macroscopic stage III melanoma patients stratified according to interferon-gamma (IFN-gamma) signature – the DONIMI study

Reijers, ILM, Rozeman, EA, Dimitriadis, P, Krijgsman, O, Bosch, LJW, Cornelissen, S, Bouwman, J, Versluis, JM, Rao, D, van de Wiel, B, Spillane, AJ, Scolyer, RA, Menzies, AM, van Akkooi, ACJ, Long, GV
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/jitc-2020-itoc7.28
Date:
October, 2020
File:
PDF, 78 KB
2020
Conversion to is in progress
Conversion to is failed